Inactivated rabies-vectored sars-cov-2 vaccine provides long-term immune response unaffected by vector immunity

HIGHLIGHTS

• who: Catherine Yankowski from the Severe acute respiratory syndrome coronavirus , (SARS-CoV-2) emerged in December , in Wuhan, China, and rapidly engulfed the world in a coronavirus disease (COVID-19) pandemicMore than , million people have been infected, resulting in over , million deaths1. Despite two-thirds of the US population being fully vaccinated, as of May, there are still over , deaths weekly in the USA (Johns Hopkins University)1. There are currently , preclinical , vaccines with , reaching FDA approval (World Health Organization)2. Our rabies virus (RABV)vectored , vaccine containing the , domain of the SARSCo, spike glycoprotein, CORAVAX, has . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.